← All trials
NCT04558697
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 21, 2019
- Primary completion
- Jun 21, 2019
- Completion date
- Sep 30, 2019
- First posted
- Sep 22, 2020
- Last posted
- Sep 22, 2020
- Enrollment
- 210
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of SarajevoLead sponsor
- University of SarajevoReponsible party - principal investigator
- University of TuzlaCollaborator
- University of SarajevoStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.